Patent issued for Concarlo-developed therapeutic peptide to treat drug-resistant brea

[News]

Concarlo Holdings LLC, has today announced that US Patent 10,702,570 was issued by the United States Patent and Trademark Office on July 07, 2020, marking the latest step in Concarlo’s journey to commercialize revolutionary medicines for metastatic breast cancer.

More... (https://www.news-medical.net/news/20200730/Patent-issued-for-Concarlo-developed-therapeutic-peptide-to-treat-drug-resistant-breast-cancer.aspx)